H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs La Jolla Institute for Immunology

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
La Jolla Institute for Immunology
CARank #FEIN 33-0328688

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPLa Jolla Institute for Immunology
Total filings80,813241
Certified %98.23%89.21%
Denied %1.09%2.07%
Withdrawn %0.61%2.07%
Cert-withdrawn %0.07%6.64%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePACA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — La Jolla Institute for Immunology

DOL case-status mix.

Outcome breakdown: Certified 89.2%, Cert-withdrawn 6.6%, Withdrawn 2.1%, Denied 2.1%
Outcome breakdown
OutcomeShare
Certified89.2%
Cert-withdrawn6.6%
Withdrawn2.1%
Denied2.1%
Certified89.2%
Cert-withdrawn6.6%
Withdrawn2.1%
Denied2.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
La Jolla Institute for Immunology
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201020
FY201118
FY201223
FY201327
FY201421
FY201527
FY201618
FY201716
FY201815
FY201915
FY20201
FY20216
FY20220
FY20232
FY202412
FY202510
FY202610

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.